{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:31:08Z","timestamp":1777501868516,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/17368-0"],"award-info":[{"award-number":["2013\/17368-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Familial hypercholesterolemia (FH) is characterized by high low-density lipoprotein cholesterol (LDL-C) levels and a high risk of early coronary heart disease. Structural alterations in the\n                    <jats:italic>LDLR<\/jats:italic>\n                    ,\n                    <jats:italic>APOB<\/jats:italic>\n                    , and\n                    <jats:italic>PCSK9<\/jats:italic>\n                    genes were not found in 20\u201340% of patients diagnosed using the Dutch Lipid Clinic Network (DCLN) criteria. We hypothesized that methylation in canonical genes could explain the origin of the phenotype in these patients. This study included 62 DNA samples from patients with a clinical diagnosis of FH according to the DCLN criteria, who previously tested negative for structural alterations in the canonical genes, and 47 DNA samples from patients with normal blood lipids (control group). All DNA samples were tested for methylation in the CpG islands of the three genes. The prevalence of FH relative to each gene was determined in both groups and the respective prevalence ratios (PRs) were calculated. The methylation analysis of\n                    <jats:italic>APOB<\/jats:italic>\n                    and\n                    <jats:italic>PCSK9<\/jats:italic>\n                    was negative in both groups, showing no relationship between methylation in these genes and the FH phenotype. As\n                    <jats:italic>the LDLR<\/jats:italic>\n                    gene has two CpG islands, we analyzed each island separately. The analysis of\n                    <jats:italic>LDLR<\/jats:italic>\n                    -island1 showed PR\u2009=\u20090.982 (CI 0.33\u20132.95; \u03c7\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.001; p\u2009=\u20090.973), also suggesting no relationship between methylation and the FH phenotype. Analysis of\n                    <jats:italic>LDLR<\/jats:italic>\n                    -island2 showed a PR of 4.12 (CI 1.43\u201311.88; \u03c7\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u200913,921; p\u2009=\u20090.00019), indicating a possible association between methylation on this island and the FH phenotype.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-34639-1","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T06:02:12Z","timestamp":1686117732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["LDLR gene\u2019s promoter region hypermethylation in patients with familial hypercholesterolemia"],"prefix":"10.1038","volume":"13","author":[{"given":"R. A.","family":"Zorzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. M. M.","family":"Suen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A.","family":"Silva-Jr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. K.","family":"Suazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L. S. C.","family":"Honorato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Jannes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D. R.","family":"Liberatore-Jr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"issue":"22","key":"34639_CR1","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","volume":"141","author":"P Hu","year":"2020","unstructured":"Hu, P. et al. Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: A systematic review and meta-analysis. Circulation 141(22), 1742\u20131759 (2020).","journal-title":"Circulation"},{"issue":"4","key":"34639_CR2","first-page":"782","volume":"117","author":"MCO Izar","year":"2021","unstructured":"Izar, M. C. O. et al. Update of the Brazilian guideline for familial hypercholesterolemia: 2021. Arq. Bras. Cardiol. 117(4), 782\u2013844 (2021).","journal-title":"Arq. Bras. Cardiol."},{"key":"34639_CR3","volume-title":"Gene Reviews","author":"E Youngblom","year":"2014","unstructured":"Youngblom, E. & Knowles, J. W. Familia hypercholesterolemia. In Gene Reviews (eds Pagon, R. A. et al. et al.) (University of Washington, 2014)."},{"key":"34639_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","volume":"16","author":"AJ Berberich","year":"2019","unstructured":"Berberich, A. J. & Hegele, R. A. The complex molecular genetics of familial hypercholesterolemia. Nat. Rev. Cardiol. 16, 9\u201320. https:\/\/doi.org\/10.1038\/s41569-018-0052-6 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"34639_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fcvm.2019.00005","volume":"6","author":"A Sarraju","year":"2019","unstructured":"Sarraju, A. & Knowles, J. W. Genetic testing and risk scores: Impact on familial hypercholesterolemia. Front. Cardiovasc. Med. 6, 5\u201320 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"34639_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","volume":"381","author":"PJ Talmud","year":"2013","unstructured":"Talmud, P. J. et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolemia: A case-control study. Lancet 381, 1293\u20131301 (2013).","journal-title":"Lancet"},{"issue":"10","key":"34639_CR7","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton, A. M. & Bird, A. CpG islands and the regulation of transcription. Genes Dev. 25(10), 1010\u20131022. https:\/\/doi.org\/10.1101\/gad.2037511 (2011).","journal-title":"Genes Dev."},{"key":"34639_CR8","volume-title":"Genetics, Epigenetic Mechanism","author":"NM Al Aboud","year":"2022","unstructured":"Al Aboud, N. M., Tupper, C. & Jialal, I. Genetics, Epigenetic Mechanism (StatPearls Publishing, 2022)."},{"key":"34639_CR9","unstructured":"Human (Homo sapiens) Genome Browser Gateway. University of California. http:\/\/www.genome.ucsc.edu"},{"key":"34639_CR10","doi-asserted-by":"publisher","first-page":"103079","DOI":"10.1016\/j.ebiom.2020.103079","volume":"61","author":"LF Reeskamp","year":"2020","unstructured":"Reeskamp, L. F. et al. Differential DNA methylation in familial hypercholesterolemia. EBioMedicine 61, 103079. https:\/\/doi.org\/10.1016\/j.ebiom.2020.103079 (2020).","journal-title":"EBioMedicine"},{"issue":"4","key":"34639_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/MOL.0000000000000299","volume":"27","author":"MP Bogsrud","year":"2016","unstructured":"Bogsrud, M. P., Ulven, S. M. & Holven, K. B. Does intrauterine exposure to hypercholesterolemia adversely affect familial hypercholesterolemia phenotype?. Curr. Opin. Lipidol. 27(4), 382\u2013387. https:\/\/doi.org\/10.1097\/MOL.0000000000000299 (2016).","journal-title":"Curr. Opin. Lipidol."},{"issue":"1","key":"34639_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2014.11.009","volume":"238","author":"CE Jannes","year":"2015","unstructured":"Jannes, C. E. et al. Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects. Atherosclerosis 238(1), 101\u2013107 (2015).","journal-title":"Atherosclerosis"},{"key":"34639_CR13","unstructured":"World Health Organization Human Genetics Program. Familial hypercholesterolemia (FH). Report of a second WHO Consultation. Geneva, 4 September 1998. (Report No. WHO\/HGN\/FH\/CONS\/99.2)."},{"key":"34639_CR14","doi-asserted-by":"publisher","first-page":"8827516","DOI":"10.1155\/2021\/8827516","volume":"20","author":"E Khodadadi","year":"2021","unstructured":"Khodadadi, E. et al. Current advances in DNA methylation analysis methods. Biomed. Res. Int. 20, 8827516. https:\/\/doi.org\/10.1155\/2021\/8827516 (2021).","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"34639_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2183\/pjab.84.321","volume":"84","author":"H Hayatsu","year":"2008","unstructured":"Hayatsu, H. Discovery of bisulfite-mediated cytosine conversion to uracil, the key reaction for DNA methylation analysis: A personal account. Proc. Jpn. Acad. Ser. B. 84(8), 321\u2013330. https:\/\/doi.org\/10.2183\/pjab.84.321 (2008).","journal-title":"Proc. Jpn. Acad. Ser. B."},{"issue":"33170","key":"34639_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3791\/3170","volume":"56","author":"K Patterson","year":"2011","unstructured":"Patterson, K., Molloy, L., Qu, W. & Clark, S. DNA methylation: Bisulfite modification and analysis. J. Vis. Exp. 56(33170), 1\u20139. https:\/\/doi.org\/10.3791\/3170 (2011).","journal-title":"J. Vis. Exp."},{"issue":"1","key":"34639_CR17","first-page":"19","volume":"48","author":"PRX Tomaz","year":"2016","unstructured":"Tomaz, P. R. X., Santos, J. R. & Santos, P. C. J. L. Applicability aspects of the melting curve analysis. RBAC 48(1), 19\u201323 (2016).","journal-title":"RBAC"},{"issue":"2","key":"34639_CR18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/1118-8561.145600","volume":"13","author":"SE Attawodi","year":"2010","unstructured":"Attawodi, S. E., Atawodi, J. C. & Dzikwi, A. A. Polymerase chain reaction: Theory, practice and application, a review. Sahel Med. J. 13(2), 54\u201363 (2010).","journal-title":"Sahel Med. J."},{"key":"34639_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2407-9-123","volume":"9","author":"E Smith","year":"2009","unstructured":"Smith, E., Jones, M. E. & Drew, P. A. Quantitation of DNA methylation by melt curve analysis. BMC Cancer 9, 123\u2013135 (2009).","journal-title":"BMC Cancer"},{"key":"34639_CR20","unstructured":"Britannica. The Editors of Encyclopaedia. \"Proportionality\". Encyclopedia Britannica (2016). https:\/\/www.britannica.com\/science\/proportionality. Accessed 20 Oct 2022."},{"key":"34639_CR21","unstructured":"Pagano, M. & Gavreau, K. Principles of biostatistics. In Comparison between two means. Thomson Learning (2004)."},{"issue":"30","key":"34639_CR22","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.1002\/sim.7059","volume":"35","author":"AR Tamhane","year":"2016","unstructured":"Tamhane, A. R., Westfall, A. O., Burkholder, G. A. & Cutter, G. R. Prevalence odds ratio versus prevalence ratio: Choice comes with consequences. Stat. Med. 35(30), 5730\u20135735. https:\/\/doi.org\/10.1002\/sim.7059 (2016) (Erratum in Stat Med. 2017; 36(23):3760).","journal-title":"Stat. Med."},{"issue":"2","key":"34639_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.11613\/bm.2013.018","volume":"23","author":"ML McHugh","year":"2013","unstructured":"McHugh, M. L. The chi-square test of independence. Biochem. Med. 23(2), 143\u2013149. https:\/\/doi.org\/10.11613\/bm.2013.018 (2013).","journal-title":"Biochem. Med."},{"issue":"7","key":"34639_CR24","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N PercieduSert","year":"2020","unstructured":"PercieduSert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biol. 18(7), e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411 (2020).","journal-title":"PLOS Biol."},{"key":"34639_CR25","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","volume":"36","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. Polygenic versus monogenic causes hypercholesterolemia ascertained clinically. Arterioscler. Thromb. Vasc. Biol. 36, 2439\u20132445. https:\/\/doi.org\/10.1161\/ATVBAHA.116.308027 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34639-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34639-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34639-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T18:14:32Z","timestamp":1729534472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34639-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34639"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34639-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2268996\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"13 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RDS received honoraria related to consulting, research, and\/or speaker activities from Abbott, Ache, Amgen, Astra Zeneca, Esperion, EMS, Getz Pharma, Kowa, Libbs, Novo-Nordisk, Novartis, Merck, MSD, Pfizer, PTC Therapeutics, and Sanofi\/Regeneron. All other authors do not have any conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9241"}}